• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化中的免疫功能障碍

Immune Dysfunction in Cirrhosis.

作者信息

Noor Mohd Talha, Manoria Piyush

机构信息

Department of Gastroenterology, Sri Aurobindo Medical College and Post Graduate Institute, Indore, India.

出版信息

J Clin Transl Hepatol. 2017 Mar 28;5(1):50-58. doi: 10.14218/JCTH.2016.00056. Epub 2017 Mar 10.

DOI:10.14218/JCTH.2016.00056
PMID:28507927
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5411357/
Abstract

Cirrhosis due to any etiology disrupts the homeostatic role of liver in the body. Cirrhosis-associated immune dysfunction leads to alterations in both innate and acquired immunity, due to defects in the local immunity of liver as well as in systemic immunity. Cirrhosis-associated immune dysfunction is a dynamic phenomenon, comprised of both increased systemic inflammation and immunodeficiency, and is responsible for 30% mortality. It also plays an important role in acute as well as chronic decompensation. Immune paralysis can accompany it, which is characterized by increase in anti-inflammatory cytokines and suppression of proinflammatory cytokines. There is also presence of increased gut permeability, reduced gut motility and altered gut flora, all of which leads to increased bacterial translocation. This increased bacterial translocation and consequent endotoxemia leads to increased blood stream bacterial infections that cause systemic inflammatory response syndrome, sepsis, multiorgan failure and death. The gut microbiota of cirrhotic patients has more pathogenic microbes than that of non-cirrhotic individuals, and this disturbs the homeostasis and favors gut translocation. Prompt diagnosis and treatment of such infections are necessary for better survival. We have reviewed the various mechanisms of immune dysfunction and its consequences in cirrhosis. Recognizing the exact pathophysiology of immune dysfunction will help treating clinicians in avoiding its complications in their patients and can lead to newer therapeutic interventions and reducing the morbidity and mortality rates.

摘要

任何病因引起的肝硬化都会破坏肝脏在体内的稳态作用。肝硬化相关的免疫功能障碍会导致先天性免疫和获得性免疫的改变,这是由于肝脏局部免疫以及全身免疫存在缺陷所致。肝硬化相关的免疫功能障碍是一种动态现象,包括全身炎症增加和免疫缺陷,其导致的死亡率为30%。它在急性和慢性失代偿中也起重要作用。免疫麻痹可能伴随出现,其特征是抗炎细胞因子增加和促炎细胞因子受到抑制。还存在肠道通透性增加、肠道蠕动减弱和肠道菌群改变的情况,所有这些都会导致细菌移位增加。这种细菌移位增加以及随之而来的内毒素血症会导致血流细菌感染增加,进而引起全身炎症反应综合征、脓毒症、多器官功能衰竭和死亡。肝硬化患者的肠道微生物群比非肝硬化个体含有更多的致病微生物,这会扰乱体内稳态并有利于肠道移位。及时诊断和治疗此类感染对于提高生存率至关重要。我们回顾了肝硬化中免疫功能障碍的各种机制及其后果。认识到免疫功能障碍的确切病理生理学将有助于临床治疗医生避免其患者出现并发症,并可能带来新的治疗干预措施,降低发病率和死亡率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de57/5411357/6904d33cbeba/JCTH-5-50-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de57/5411357/6904d33cbeba/JCTH-5-50-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de57/5411357/6904d33cbeba/JCTH-5-50-g001.jpg

相似文献

1
Immune Dysfunction in Cirrhosis.肝硬化中的免疫功能障碍
J Clin Transl Hepatol. 2017 Mar 28;5(1):50-58. doi: 10.14218/JCTH.2016.00056. Epub 2017 Mar 10.
2
Immune dysfunction in cirrhosis.肝硬化中的免疫功能障碍。
World J Gastroenterol. 2014 Mar 14;20(10):2564-77. doi: 10.3748/wjg.v20.i10.2564.
3
Implications and Management of Cirrhosis-Associated Immune Dysfunction Before and After Liver Transplantation.肝移植前后肝硬化相关免疫功能障碍的影响及管理
Liver Transpl. 2022 Apr;28(4):700-716. doi: 10.1002/lt.26353. Epub 2021 Nov 29.
4
Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance.肝硬化相关免疫功能障碍:特征和临床相关性。
J Hepatol. 2014 Dec;61(6):1385-96. doi: 10.1016/j.jhep.2014.08.010. Epub 2014 Aug 15.
5
Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis.微生物群与肠-肝轴:肝硬化中的细菌易位、炎症和感染
World J Gastroenterol. 2014 Dec 7;20(45):16795-810. doi: 10.3748/wjg.v20.i45.16795.
6
Immune Dysfunction and Albumin-Related Immunity in Liver Cirrhosis.肝硬化中的免疫功能障碍和白蛋白相关免疫。
Mediators Inflamm. 2019 Feb 25;2019:7537649. doi: 10.1155/2019/7537649. eCollection 2019.
7
Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg.肠-肝轴、肝硬化和门静脉高压:先有鸡还是先有蛋。
Hepatol Int. 2018 Feb;12(Suppl 1):24-33. doi: 10.1007/s12072-017-9798-x. Epub 2017 May 26.
8
The shaping of gut immunity in cirrhosis.肝硬化中肠道免疫的形成。
Front Immunol. 2023 Apr 14;14:1139554. doi: 10.3389/fimmu.2023.1139554. eCollection 2023.
9
Gut-derived systemic inflammation as a driver of depression in chronic liver disease.肠道源性全身炎症作为慢性肝病中抑郁症的驱动因素。
J Hepatol. 2022 Mar;76(3):665-680. doi: 10.1016/j.jhep.2021.11.008. Epub 2021 Nov 17.
10
Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia.肝硬化中的肠-肝轴:如何应对肠道渗漏和内毒素血症。
World J Hepatol. 2015 Mar 27;7(3):425-42. doi: 10.4254/wjh.v7.i3.425.

引用本文的文献

1
Mechanical interactions impact the functions of immune cells and their application in immunoengineering.机械相互作用影响免疫细胞的功能及其在免疫工程中的应用。
Adv Ther (Weinh). 2025 Jun 25. doi: 10.1002/adtp.202500067.
2
CD8 T Cell Hyperfunction and Reduced Tumour Control in Murine Models of Advanced Liver Disease.晚期肝病小鼠模型中CD8 T细胞功能亢进与肿瘤控制减弱
Eur J Immunol. 2025 Aug;55(8):e70026. doi: 10.1002/eji.70026.
3
How Do Polymorphonuclear Counts in Ascitic Fluid Correlate to Hospital Outcome.腹水多形核细胞计数与医院结局如何相关。

本文引用的文献

1
Non-HFE iron overload as a surrogate marker of disease severity in patients of liver cirrhosis.非HFE铁过载作为肝硬化患者疾病严重程度的替代标志物。
Indian J Gastroenterol. 2016 Jan;35(1):33-9. doi: 10.1007/s12664-016-0623-6. Epub 2016 Feb 13.
2
Acute-on-chronic liver failure: terminology, mechanisms and management.急性肝衰竭:术语、机制与管理。
Nat Rev Gastroenterol Hepatol. 2016 Mar;13(3):131-49. doi: 10.1038/nrgastro.2015.219. Epub 2016 Feb 3.
3
Association between lymphocyte-to-monocyte ratio (LMR) and the mortality of HBV-related liver cirrhosis: a retrospective cohort study.
J Community Hosp Intern Med Perspect. 2025 May 5;15(3):15-22. doi: 10.55729/2000-9666.1475. eCollection 2025.
4
Nanoparticle-based therapeutic strategies for chronic liver diseases: Advances and insights.基于纳米颗粒的慢性肝病治疗策略:进展与见解
Liver Res. 2025 Apr 12;9(2):104-117. doi: 10.1016/j.livres.2025.04.002. eCollection 2025 Jun.
5
Prognostic Value of Inflammatory Markers in Septic Critically Ill Patients with Chronic Liver Disease: A Retrospective Analysis.炎症标志物对合并慢性肝病的脓毒症重症患者的预后价值:一项回顾性分析
Turk J Gastroenterol. 2025 Jun 16;36(9):600-608. doi: 10.5152/tjg.2025.24794.
6
Early prediction of colorectal adenoma risk: leveraging large-language model for clinical electronic medical record data.结直肠腺瘤风险的早期预测:利用大语言模型处理临床电子病历数据
Front Oncol. 2025 May 15;15:1508455. doi: 10.3389/fonc.2025.1508455. eCollection 2025.
7
Neutrophil-derived ratios as predictors of short-term mortality in HBV-associated decompensated cirrhosis.中性粒细胞衍生比率作为乙肝相关失代偿期肝硬化短期死亡率的预测指标
BMC Gastroenterol. 2025 May 26;25(1):404. doi: 10.1186/s12876-025-03991-z.
8
Effectiveness and safety evaluation of terlipressin in the treatment of intestinal paralysis in end-stage liver disease.特利加压素治疗终末期肝病肠麻痹的有效性和安全性评估
BMC Gastroenterol. 2025 Apr 23;25(1):286. doi: 10.1186/s12876-025-03910-2.
9
The Covert Side of Ascites in Cirrhosis: Cellular and Molecular Aspects.肝硬化腹水的隐匿面:细胞与分子层面
Biomedicines. 2025 Mar 10;13(3):680. doi: 10.3390/biomedicines13030680.
10
Molecular MRI of T-cell immune response to cryoablation in immunologically hot . cold hepatocellular carcinoma.免疫活性高/低的肝细胞癌中T细胞对冷冻消融免疫反应的分子磁共振成像
JHEP Rep. 2024 Dec 4;7(3):101294. doi: 10.1016/j.jhepr.2024.101294. eCollection 2025 Mar.
淋巴细胞与单核细胞比值(LMR)与乙型肝炎病毒相关肝硬化死亡率的关联:一项回顾性队列研究。
BMJ Open. 2015 Aug 21;5(8):e008033. doi: 10.1136/bmjopen-2015-008033.
4
The gut microbiota and liver disease.肠道微生物群与肝脏疾病
Cell Mol Gastroenterol Hepatol. 2015 May 1;1(3):275-284. doi: 10.1016/j.jcmgh.2015.04.003.
5
Gut microbiota-related complications in cirrhosis.肝硬化中与肠道微生物群相关的并发症。
World J Gastroenterol. 2014 Nov 14;20(42):15624-31. doi: 10.3748/wjg.v20.i42.15624.
6
Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance.肝硬化相关免疫功能障碍:特征和临床相关性。
J Hepatol. 2014 Dec;61(6):1385-96. doi: 10.1016/j.jhep.2014.08.010. Epub 2014 Aug 15.
7
Granulocyte colony-stimulating factor in severe alcoholic hepatitis: a randomized pilot study.粒细胞集落刺激因子治疗重症酒精性肝炎:一项随机初步研究。
Am J Gastroenterol. 2014 Sep;109(9):1417-23. doi: 10.1038/ajg.2014.154. Epub 2014 Jun 17.
8
Immune dysfunction in cirrhosis.肝硬化中的免疫功能障碍。
World J Gastroenterol. 2014 Mar 14;20(10):2564-77. doi: 10.3748/wjg.v20.i10.2564.
9
Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013.肝硬化中的细菌感染:基于 EASL 特别会议 2013 年的立场声明。
J Hepatol. 2014 Jun;60(6):1310-24. doi: 10.1016/j.jhep.2014.01.024. Epub 2014 Feb 12.
10
Pathological bacterial translocation in liver cirrhosis.肝硬化中的病理性细菌移位
J Hepatol. 2014 Jan;60(1):197-209. doi: 10.1016/j.jhep.2013.07.044. Epub 2013 Aug 28.